Literature DB >> 14500641

Diversity of clonal T cell proliferation is mediated by differential expression of CD152 (CTLA-4) on the cell surface of activated individual T lymphocytes.

Frank Maszyna1, Holger Hoff, Désirée Kunkel, Andreas Radbruch, Monika C Brunner-Weinzierl.   

Abstract

Inhibitory effects of CD152 (CTLA-4) engagement during T cell activation have been described. To date, such effects could only be correlated to CD152 expression at the population level because expression of CD152 on the cell surface is too low to be assessed by conventional immunofluorescence on the single cell level. In this study, we use magnetofluorescent liposomes for the immunofluorescent detection of surface CD152-expressing CD4(+) T cells and show that, despite the fact that nearly all cells express intracellular CD152, only a fraction of 12% of activated T cells expresses surface CD152 at any given time point. Surface CD152(+) T cells appear with similar kinetics after primary or secondary activation in vitro. However, the frequency of surface CD152(+) T cells 48 h postactivation is 2-fold higher during secondary activation. Surface expression of CD152 is independent of the proliferative history of an activated T cell. Instruction of T cells for surface expression of CD152 rather depends on the time elapsed since the onset of activation, with a maximum at 48 h, and requires less than 12 h of Ag exposure. CD152(-) T cells, when isolated by cell sorting and restimulated, continue to proliferate. CD152 blockade has no effect on their proliferation. Isolated surface CD152(+) T cells do not proliferate upon restimulation unless CD152 is blocked. CD152 thus acts directly and autonomously on individual activated and proliferating T lymphocytes. Due to its heterogeneous expression on the cell surface of activated Th cells, CD152 might diversify the T cell response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500641     DOI: 10.4049/jimmunol.171.7.3459

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells.

Authors:  Priscilla Do; Kyle A Beckwith; Carolyn Cheney; Minh Tran; Larry Beaver; Brittany G Griffin; Xiaokui Mo; Yang Liu; Rosa Lapalombella; Erin Hertlein; Natarajan Muthusamy; John C Byrd
Journal:  J Immunol       Date:  2019-03-25       Impact factor: 5.422

2.  Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152).

Authors:  Ulrike Gimsa; Anita ØRen; Pushpa Pandiyan; Daniela Teichmann; Ingo Bechmann; Robert Nitsch; Monika C Brunner-Weinzierl
Journal:  J Mol Med (Berl)       Date:  2004-03-09       Impact factor: 4.599

3.  Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine.

Authors:  Juanita Shaffer; Jean Villard; Terry K Means; Stephen Alexander; David Dombkowski; Bimalangshu R Dey; Steven McAfee; Karen K Ballen; Susan Saidman; Frederic I Preffer; David H Sachs; Thomas R Spitzer; Megan Sykes
Journal:  Exp Hematol       Date:  2007-07       Impact factor: 3.084

4.  Suppression of activation and costimulatory signaling in splenic CD4+ T cells after trauma-hemorrhage reduces T-cell function: a mechanism of post-traumatic immune suppression.

Authors:  Chi-Hsun Hsieh; Jun-Te Hsu; Ya-Ching Hsieh; Michael Frink; Raghavan Raju; William J Hubbard; Kirby I Bland; Irshad H Chaudry
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

Review 5.  Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation.

Authors:  Ulrike Gimsa; N Avrion Mitchison; Monika C Brunner-Weinzierl
Journal:  Mediators Inflamm       Date:  2013-08-20       Impact factor: 4.711

Review 6.  CTLA-4 trafficking and surface expression.

Authors:  Elke Valk; Christopher E Rudd; Helga Schneider
Journal:  Trends Immunol       Date:  2008-05-09       Impact factor: 16.687

7.  CD152 (CTLA-4) determines CD4 T cell migration in vitro and in vivo.

Authors:  Karin Knieke; Holger Hoff; Frank Maszyna; Paula Kolar; Arnhild Schrage; Alf Hamann; Gudrun F Debes; Monika C Brunner-Weinzierl
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

8.  CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function.

Authors:  Pushpa Pandiyan; Dagmar Gärtner; Osman Soezeri; Andreas Radbruch; Klaus Schulze-Osthoff; Monika C Brunner-Weinzierl
Journal:  J Exp Med       Date:  2004-03-08       Impact factor: 14.307

Review 9.  Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases.

Authors:  Monika C Brunner-Weinzierl; Holger Hoff; Gerd-R Burmester
Journal:  Arthritis Res Ther       Date:  2004-03-03       Impact factor: 5.156

10.  Ipilimumab augments antitumor activity of bispecific antibody-armed T cells.

Authors:  Hiroshi Yano; Archana Thakur; Elyse N Tomaszewski; Minsig Choi; Abhinav Deol; Lawrence G Lum
Journal:  J Transl Med       Date:  2014-07-09       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.